Nasdaq: ME

SOUTH SAN FRANCISCO, CALIFORNIA, MAY 09, 2023 (GLOBE NEWSWIRE) — 23andMe Holdings (Nasdaq: ME) (23andMe), a pace-setter in human genetics and biopharmaceuticals, lately launched a brand new record on lupus, a prolonged autoimmune illness. In some critical instances, it can result in everlasting tissue harm, and might have an effect on the outside, joints, middle, … Read more

This system goals to extend get admission to to details about sickle cellular provider standing, and to provide assets to folks with sickle cellular characteristics and sickle cellular illness. It expands present projects between 23andMe and the Morehouse Faculty of Drugs to extend fairness in genetics and genomics ATLANTA AND SOUTH SAN FRANCISCO, Calif., April … Read more